Sleep Technology: Wearables, CPAP Tools, and Apps

Sleep Technology: Wearables, CPAP Tools, and Apps

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.

These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.

In Brief: Most consumer sleep devices do not measure the brain, eye, and muscle signals that define sleep; they infer it from movement and pulse and report stages and scores. Those estimates are reasonable for sleep timing and duration but weak for staging and overall sleep quality. CPAP data and digital cognitive behavioral therapy for insomnia are different in kind, because they reflect real treatment and carry real evidence. The cardiovascular features now appearing on wrists — rhythm alerts, oxygen readings, cuffless blood pressure — are screening signals at best, not diagnoses. Technology helps when it changes a decision, and hurts when it turns sleep into a performance.

Sleep technology did not grow out of sleep medicine. It grew out of consumer electronics: miniaturized sensors, continuous data collection, and software that converts physiologic signals into a nightly sleep score. Many people now wake to graphs that look precise even when the measurement underneath is indirect. In the clinic, sleep is defined by brain activity, eye movements, and muscle tone, recorded together with breathing and oxygen during a sleep study. Most consumer devices measure none of those defining signals. They infer sleep from motion and cardiovascular patterns, then translate those inferences into stages, “quality,” and readiness using proprietary algorithms. Sometimes the estimates are directionally useful. Sometimes they mislead. For cardiovascular health the difference is not academic, because untreated sleep apnea can coexist with a reassuring readout, and fixation on metrics can manufacture the very insomnia it claims to track. Technology helps when it changes a decision, and hurts when it turns sleep into a performance.

What Consumer Trackers Actually Measure

Most consumer trackers are built on actigraphy, which is movement detection, sometimes combined with pulse and related signals.(1) Accelerometers measure motion on the assumption that stillness means sleep. That assumption holds often enough to make actigraphy useful for sleep timing and duration, but it fails during quiet wakefulness and during restless sleep. Optical pulse sensing, called photoplethysmography, detects blood-volume changes at the skin. Heart rate tends to fall in non-REM sleep and rise during REM and arousals, but it is heavily swayed by medications, alcohol, stress, fever, pain, fitness, and arrhythmia. Heart rate variability reflects autonomic influences on the heart and can be directionally informative for some users, but it is artifact-prone and not standardized across brands. Some wearables also estimate oxygen saturation and may surface desaturation patterns suggestive of disordered breathing, yet consumer oximetry is vulnerable to motion and poor perfusion and is not diagnostic. Respiratory rate, when shown, is usually inferred indirectly, and its accuracy varies widely.

The honest way to read these devices is to separate what they sense from what they claim.

What Trackers Infer, and Why the Difference Matters

Polysomnography defines sleep stages from brain waves, eye movements, and muscle tone. Consumer devices do not record those signals, so they reconstruct stages from movement and pulse. Validation studies tell a consistent story: total sleep time is reasonably accurate on average, but agreement is weak for time spent awake after falling asleep and weaker still for individual stages.(2, 3, 4) The limitation is physiologic, not a software bug waiting to be patched. Different brain-defined states can look nearly identical at the level of motion and pulse. Quiet wakefulness gets read as light sleep. Sleep broken by brief awakenings gets smoothed into something continuous. REM is misclassified because its heart-rate signature overlaps with other states and every brand draws the lines differently. The practical translation is simple: trust these devices for when and how long you slept, and treat their “deep,” “REM,” and “quality” figures as low-confidence estimates rather than measurements.

That distinction maps onto what is worth watching and what is worth ignoring.

A few device patterns prompt predictable questions, and most have calm answers. Bedtimes and wake times that swing day to day point to circadian and behavioral irregularity. The reasonable response is to anchor a consistent wake time and use the device only to confirm the trend. A “normal” sleep total paired with daily sleepiness is the pattern that should not reassure, because the tracker may be missing fragmentation or apnea; symptoms, not the score, should drive evaluation. Repeated overnight oxygen dips alongside snoring, witnessed pauses, or sleepiness justify a formal assessment, but the dips themselves are not a diagnosis. A nightly high “awake” figure without symptoms is usually misclassification, and low “deep” or “REM” percentages are usually stage-inference noise. A “readiness” score that lurches around is a composite reacting to artifact and context, and the right move is to read broad trends or, if daily checking breeds anxiety, to stop checking daily.

When Trackers Help, and When They Harm

Trackers earn their keep in a few specific ways. They are good at exposing inconsistent timing and chronic short sleep, and irregular sleep timing has been associated with cardiovascular events in cohort data.(5) That association comes from observational research and is reported as a relative increase, so it describes risk across groups rather than a guaranteed outcome for one person. The absolute change for any individual depends on baseline risk. Trackers also help people run honest experiments with alcohol, late caffeine, late meals, and evening light, seen through timing and awakenings rather than stage scores. Recurrent oxygen dips can rightly prompt evaluation for sleep apnea, and weeks of timing and duration data often beat a patient’s retrospective estimate when talking with a clinician.

The harms are just as real. Orthosomnia is sleep disturbance created or amplified by fixation on sleep metrics, and when tracking raises anxiety or bedtime vigilance it becomes counterproductive.(6) False reassurance is the mirror image, because a good-looking night does not exclude sleep apnea or another disorder. Stage fixation sits in between: given how weakly consumer staging agrees with the gold standard, worrying about “low deep sleep” usually means worrying about measurement noise.(2, 3, 4)

CPAP Data: Genuinely Clinical

CPAP data belongs in a different category, because it reflects treatment delivery and physiologic effect rather than an inference about sleep. Effective therapy holds the airway open, blunts the intermittent drops in oxygen and the arousals of obstructive events, restores sleep continuity, and quiets the repetitive sympathetic surges that punctuate untreated apnea. Modern machines record usage hours, mask leak, residual events, and pressure, and those numbers guide real troubleshooting.(7) Coverage rules typically require documented adherence, commonly at least four hours per night on at least seventy percent of nights during an initial period, before continued coverage.(8) The data becomes most powerful when it leads somewhere, and telemonitoring paired with proactive support improved adherence in a randomized trial, whereas passive monitoring with no follow-up did much less.(9) A high leak usually points to mask fit or mouth leak and is addressed through fit, mask type, and humidification with a clinician or equipment provider. A rising residual event rate suggests ongoing obstruction or treatment-emergent events and warrants a clinical conversation rather than self-adjustment.

Sleep Apps: Where the Evidence Is

Among apps, the strongest evidence belongs to digital cognitive behavioral therapy for insomnia, which randomized trials support for insomnia severity and sleep efficiency, with benefit sustained at one year.(10, 11) Mindfulness and relaxation programs show modest benefit for insomnia in meta-analysis and can help by lowering hyperarousal.(12) Claims of “inducing deep sleep” or “optimizing stages” through sounds or vibration deserve skepticism until rigorous evidence exists, both because the underlying stage measurement is weak and because the claims usually outrun the data.

Light, Temperature, and Noise

Environmental technology works when it acts on real physiology rather than on a metric. Evening light from bright, blue-enriched screens measurably shifts circadian timing and next-morning alertness, which is the physiologic rationale for dimming and reducing screen exposure near bedtime.(13) Cooler rooms and lower noise tend to improve continuity, and although the trial evidence varies in strength the risk is low. Most of the benefit, in the end, comes from removing the arousal triggers — light, noise, discomfort — that fragment sleep with micro-awakenings the sleeper never remembers.

Cardiovascular Features: Rhythm, Pressure, Oxygen

The cardiovascular features migrating onto wrists are the ones most likely to be misread as diagnoses. Smartwatch rhythm detection can flag possible atrial fibrillation at population scale, but it screens rather than diagnoses, and false positives occur. In the large Apple Heart Study, only about a third of participants who received an irregular-pulse notification showed atrial fibrillation on a confirmatory patch.(14) Cuffless blood pressure based on pulse-timing methods remains an active research area that drifts without calibration, and consumer versions are not a substitute for a validated cuff.(15) Wearable oxygen readings may suggest desaturation but cannot diagnose obstructive sleep apnea or confirm that CPAP is working. In each case the device produces a prompt, not a verdict.

Common Assumptions Measured Against the Physiology

The Bottom Line

Sleep technology runs from genuinely useful tools to sophisticated distraction. Consumer trackers are most reliable for sleep timing and duration and least reliable for staging and composite scoring. CPAP data is clinically meaningful and can guide therapy when someone acts on it. Digital cognitive behavioral therapy for insomnia has real evidence and can reach people at scale. Light and other environmental tools can help through real physiology, even as many products promise far more than the evidence supports. The cardiovascular features now on wrists are prompts to investigate, not diagnoses to accept. For cardiovascular health the standard is not whether a device produces appealing data; it is whether the technology changes a behavior or a treatment decision in a way that matters. Technology helps when it changes a decision, and hurts when it turns sleep into a performance.

What Comes Next

The next article turns from measuring sleep to improving it, examining which optimization strategies are supported by physiology and which are mostly marketing — and why, for the cardiovascular system, the goal is protecting the overnight processes that sleep is supposed to deliver.

Key Terms

Actigraphy: Movement-based estimation of sleep and wake, the foundation of most consumer trackers.(1)

Photoplethysmography (PPG): Optical sensing that estimates pulse from blood-volume changes at the skin.

Heart rate variability (HRV): Beat-to-beat variation influenced by autonomic balance; not standardized across consumer devices.

Polysomnography (PSG): The gold standard for sleep testing, recording brain waves, eye movements, and muscle tone alongside breathing and oxygen.

Residual AHI: The apnea–hypopnea event rate a CPAP machine records during therapy, used to judge how well treatment is working.

Orthosomnia: Sleep disruption caused or worsened by an unhealthy preoccupation with sleep-tracker metrics.(6)

Atrial fibrillation (AF): An irregular atrial rhythm associated with stroke risk; smartwatch detection is a screen, not a diagnosis.

References

1. Ancoli-Israel S, Martin JL, Blackwell T, et al. The SBSM guide to actigraphy monitoring: clinical and research applications. Behav Sleep Med. 2015;13(Suppl 1):S4-S38. doi:10.1080/15402002.2015.1046356.
2. de Zambotti M, Goldstone A, Claudatos S, Colrain IM, Baker FC. A validation study of Fitbit Charge 2 compared with polysomnography in adults. Chronobiol Int. 2018;35(4):465-476. doi:10.1080/07420528.2017.1413578. PMID: 29235907.
3. Roomkham S, Lovell D, Cheung J, Perrin D. Promises and challenges in the use of consumer-grade devices for sleep monitoring. IEEE Rev Biomed Eng. 2018;11:53-67. doi:10.1109/RBME.2018.2811735. PMID: 29993607.
4. Haghayegh S, Khoshnevis S, Smolensky MH, Diller KR, Castriotta RJ. Accuracy of wristband Fitbit models in assessing sleep: systematic review and meta-analysis. J Med Internet Res. 2019;21(11):e16273. doi:10.2196/16273. PMID: 31778122.
5. Huang T, Mariani S, Redline S. Sleep irregularity and risk of cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol. 2020;75(9):991-999. doi:10.1016/j.jacc.2019.12.054.
6. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351-354. doi:10.5664/jcsm.6472. PMID: 27855740.
7. Schwab RJ, Badr SM, Epstein LJ, et al. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. Am J Respir Crit Care Med. 2013;188(5):613-620. doi:10.1164/rccm.201307-1282ST. PMID: 23992588.
8. Centers for Medicare and Medicaid Services. Local Coverage Determination: Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea. 2021.
9. Hwang D, Chang JW, Benjafield AV, et al. Effect of telemedicine education and telemonitoring on continuous positive airway pressure adherence: the Tele-OSA randomized trial. Am J Respir Crit Care Med. 2018;197(1):117-126. PMID: 28858567.
10. Ritterband LM, Thorndike FP, Ingersoll KS, et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry. 2017;74(1):68-75. doi:10.1001/jamapsychiatry.2016.3249. PMID: 27902836.
11. Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1-10. doi:10.1016/j.smrv.2015.10.004. PMID: 26615572.
12. Gong H, Ni CX, Liu YZ, et al. Mindfulness meditation for insomnia: a meta-analysis of randomized controlled trials. J Psychosom Res. 2016;89:1-6. doi:10.1016/j.jpsychores.2016.07.016.
13. Cajochen C, Frey S, Anders D, et al. Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J Appl Physiol. 2011;110(5):1432-1438. doi:10.1152/japplphysiol.00165.2011.
14. Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909-1917. doi:10.1056/NEJMoa1901183. PMID: 31722151.
15. Mukkamala R, Hahn JO, Inan OT, et al. Toward ubiquitous blood pressure monitoring via pulse transit time: theory and practice. IEEE Trans Biomed Eng. 2015;62(8):1879-1901. doi:10.1109/TBME.2015.2441951. PMID: 26057530.

HeartBuddi • Your heart. Own it.